Related Experiment Video
Updated: Mar 26, 2026

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7
Farhoud Faraji1,2, Ying Hu3, Howard H Yang1
1Metastasis Susceptibility Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Abstract:
Accumulating evidence supports the role of an aberrant transcriptome as a driver of metastatic potential. Deadenylation is a general regulatory node for post-transcriptional control by microRNAs and other determinants of RNA stability. Previously, we demonstrated that the CCR4-NOT scaffold component Cnot2 is an inherited metastasis susceptibility gene. In this study, using orthotopic metastasis assays and genetically engineered mouse models, we show that one of the enzymatic subunits of the CCR4-NOT complex, Cnot7, is also a metastasis modifying gene. We demonstrate that higher expression of Cnot7 drives tumor cell autonomous metastatic potential, which requires its deadenylase activity. Furthermore, metastasis promotion by CNOT7 is dependent on interaction with CNOT1 and TOB1. CNOT7 ribonucleoprotein-immunoprecipitation (RIP) and integrated transcriptome wide analyses reveal that CNOT7-regulated transcripts are enriched for a tripartite 3'UTR motif bound by RNA-binding proteins known to complex with CNOT7, TOB1, and CNOT1. Collectively, our data support a model of CNOT7, TOB1, CNOT1, and RNA-binding proteins collectively exerting post-transcriptional control on a metastasis suppressive transcriptional program to drive tumor cell metastasis.
Insights
The CCR4-NOT complex subunit Cnot7 promotes cancer metastasis by regulating RNA stability. Its deadenylase activity, along with interactions with CNOT1 and TOB1, controls gene expression to drive tumor cell spread.
Area of Science:
- Molecular Biology
- Cancer Research
- Transcriptional Regulation
Background:
- Aberrant transcriptomes drive cancer metastasis.
- Deadenylation regulates RNA stability and microRNA control.
- CCR4-NOT complex subunit Cnot2 is a known metastasis susceptibility gene.
Purpose of the Study:
- To investigate the role of Cnot7, an enzymatic subunit of the CCR4-NOT complex, in cancer metastasis.
- To determine the mechanism by which Cnot7 influences metastatic potential.
Main Methods:
- Orthotopic metastasis assays in mouse models.
- Genetically engineered mouse models.
- Ribonucleoprotein-immunoprecipitation (RIP) followed by transcriptome-wide analyses.
Main Results:
- Cnot7 expression promotes tumor cell-autonomous metastatic potential, dependent on its deadenylase activity.
- CNOT7-mediated metastasis promotion requires interaction with CNOT1 and TOB1.
- CNOT7-regulated transcripts are enriched for specific 3'UTR motifs involved in RNA-binding protein complexes.
Conclusions:
- CNOT7 acts as a metastasis-modifying gene.
- CNOT7, TOB1, CNOT1, and associated RNA-binding proteins cooperatively control a metastasis-suppressive program via post-transcriptional regulation.
- This coordinated action drives tumor cell metastasis.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Abnormal Proliferation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

